Shandong Wohua Pharmaceutical Co., Ltd.

Symbol: 002107.SZ

SHZ

5.04

CNY

Market price today

  • 68.2150

    P/E Ratio

  • -0.2377

    PEG Ratio

  • 2.91B

    MRK Cap

  • 0.00%

    DIV Yield

Shandong Wohua Pharmaceutical Co., Ltd. (002107-SZ) Stock Price & Analysis

Shares Outstanding

0M

Gross Profit Margin

0.73%

Operating Profit Margin

0.04%

Net Profit Margin

0.05%

Return on Assets

0.04%

Return on Equity

0.05%

Return on Capital Employed

0.04%

Company general description and statistics

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO:Ms. Yingzi Zeng
Full-time employees:1353
City:Weifang
Address:No. 3517 Liyuan Street
IPO:2007-01-24
CIK:

Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. It offers Xinkeshu tablets, Naoxueshu oral solutions, Tongluo Huayu capsules, and oral liquids for cardiovascular and cerebrovascular; respiratory system drugs; medicines for women and children; urinary system drugs; digestive system drugs; anti-rheumatic drugs; and drugs for soothe the nerves. The company is based in Weifang, China. Shandong Wohua Pharmaceutical Co., Ltd. is a subsidiary of Beijing Zhongzheng Wanrong Investment(Group) Co., Ltd.

General Outlook

When we look at how much money they make before expenses, they keep 0.734% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.040%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.049%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust 0.037% return, is a testament to Shandong Wohua Pharmaceutical Co., Ltd.'s adeptness in optimizing resource deployment. Shandong Wohua Pharmaceutical Co., Ltd.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.054%. Furthermore, the proficiency of Shandong Wohua Pharmaceutical Co., Ltd. in capital utilization is underscored by a remarkable 0.040% return on capital employed.

Stock Prices

Shandong Wohua Pharmaceutical Co., Ltd.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $4.98, while its low point bottomed out at $4.82. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Shandong Wohua Pharmaceutical Co., Ltd.'s stock market.

Liquidity Ratios

Analyzing 002107.SZ liquidity ratios reveals its financial health of the firm. The current ratio of 234.94% gauges short-term asset coverage for liabilities. The quick ratio (184.21%) assesses immediate liquidity, while the cash ratio (153.65%) indicates cash reserves.

cards.indicatorcards.value
Current Ratio234.94%
Quick Ratio184.21%
Cash Ratio153.65%

Profitability Ratios

002107.SZ profitability indicators offer a lens into its earnings landscape. A pretax profit margin of 4.55% underscores its earnings before tax deductions. The effective tax rate stands at 17.44%, revealing its tax efficiency. The net income per EBT, 107.02%, and the EBT per EBIT, 114.95%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of 3.96%, we grasp its operational profitability.

cards.indicatorcards.value
Pretax Profit Margin4.55%
Effective Tax Rate17.44%
Net Income per EBT107.02%
EBT per EBIT114.95%
EBIT per Revenue3.96%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 2.35, it details the span from stock purchase to revenue. The 2 days it takes to settle debts showcases its creditor relations. Meanwhile, a 2 cash conversion cycle and 972.02% receivables turnover rate reflect its cash flow efficiency and credit management, respectively.

cards.indicatorcards.value
Days of Sales Outstanding184
Days of Inventory Outstanding219
Operating Cycle256.26
Days of Payables Outstanding89
Cash Conversion Cycle167
Receivables Turnover9.72
Payables Turnover4.08
Inventory Turnover1.67
Fixed Asset Turnover2.35
Asset Turnover0.76

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, 0.26, and free cash flow per share, 0.26, depict cash generation on a per-share basis. The cash per share value, 0.79, showcases liquidity position. Lastly, the operating cash flow sales ratio, 0.17, offers insight into cash flow relative to sales.

cards.indicatorcards.value
Operating Cash Flow per Share0.26
Free Cash Flow per Share0.26
Cash per Share0.79
Operating Cash Flow Sales Ratio0.17
Free Cash Flow to Operating Cash Flow Ratio0.99
Cash Flow Coverage Ratio215.09
Short Term Coverage Ratio215.09
Capital Expenditure Coverage Ratio69.06
Dividend Paid and Capex Coverage Ratio69.06

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 0.06%, highlights its total liabilities relative to assets. An interest coverage of 1269.10 indicates its ability to manage interest expenses.

cards.indicatorcards.value
Debt Ratio0.06%
Total Debt to Capitalization0.09%
Interest Coverage1269.10
Cash Flow to Debt Ratio215.09
Company Equity Multiplier1.43

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 1.55, provides a glimpse into top-line earnings distributed across each share. Net income per share, 0.10, reflects the portion of profit attributed to each share. The book value per share, 1.40, represents the net asset value distributed per share, while the tangible book value per share, 1.35, excludes intangible assets.

cards.indicatorcards.value
Revenue Per Share1.55
Net Income Per Share0.10
Book Value Per Share1.40
Tangible Book Value Per Share1.35
Shareholders Equity Per Share1.40
Interest Debt Per Share-0.03

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -11.87%, indicates top-line expansion, while the gross profit growth, -14.54%, reveals profitability trends. EBIT growth, -58.75%, and operating income growth, -58.75%, offer insights into operational profitability progression. The net income growth, -45.27%, showcases bottom-line expansion, and the EPS growth, -47.37%, measures the growth in earnings per share.

cards.indicatorcards.value
Revenue Growth-11.87%
Gross Profit Growth-14.54%
EBIT Growth-58.75%
Operating Income Growth-58.75%
Net Income Growth-45.27%
EPS Growth-47.37%
EPS Diluted Growth-47.37%
Dividends per Share Growth-100.00%
Operating Cash Flow Growth-30.23%
Free Cash Flow Growth-29.11%
10-Year Revenue Growth per Share277.72%
5-Year Revenue Growth per Share12.34%
3-Year Revenue Growth per Share-11.11%
10-Year Operating CF Growth per Share820.67%
5-Year Operating CF Growth per Share16.55%
3-Year Operating CF Growth per Share-34.25%
10-Year Net Income Growth per Share497.30%
5-Year Net Income Growth per Share25.23%
3-Year Net Income Growth per Share-67.15%
10-Year Shareholders Equity Growth per Share43.68%
5-Year Shareholders Equity Growth per Share31.87%
3-Year Shareholders Equity Growth per Share-0.26%
3-Year Dividend per Share Growth per Share-100.00%
Receivables Growth-27.34%
Inventory Growth2.09%
Asset Growth4.07%
Book Value per Share Growth7.87%
Debt Growth93.71%
R&D Expense Growth-13.59%
SGA Expenses Growth4.19%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 3,105,289,307, captures the company's total value, considering both debt and equity. Income quality, 2.20, assesses the reliability of reported earnings. The sales, general, and administrative to revenue ratio, 0.02, gauges operational efficiency, while the research and development to revenue, 4.84%, highlights investment in innovation. The ratio of intangibles to total assets, 6.06%, indicates the value of non-physical assets, and capex to operating cash flow, -2.10%, measures reinvestment capability.

cards.indicatorcards.value
Enterprise Value3,105,289,307
Income Quality2.20
Sales General and Administrative to Revenue0.02
Research and Development to Revenue4.84%
Intangibles to Total Assets6.06%
Capex to Operating Cash Flow-2.10%
Capex to Revenue-0.30%
Capex to Depreciation-8.17%
Graham Number1.79
Return on Tangible Assets5.46%
Graham Net Net0.47
Working Capital385,011,326
Tangible Asset Value782,054,071
Net Current Asset Value379,700,109
Average Receivables143,215,812
Average Payables49,103,411
Average Inventory147,560,615.5
Days Sales Outstanding49
Days Payables Outstanding80
Days of Inventory On Hand225
ROIC5.00%
ROE0.07%

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, 3.60, and the price to book ratio, 3.60, reflect the market's valuation relative to the company's book value. The price to sales ratio, 3.32, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, 19.51, and price to operating cash flows, 19.22, gauge market valuation against cash flow metrics.

cards.indicatorcards.value
Price Book Value Ratio3.60
Price to Book Ratio3.60
Price to Sales Ratio3.32
Price Cash Flow Ratio19.22
Price Earnings to Growth Ratio-0.24
Enterprise Value Multiple70.22
Price Fair Value3.60
Price to Operating Cash Flow Ratio19.22
Price to Free Cash Flows Ratio19.51
Price to Tangible Book Ratio4.35
Enterprise Value to Sales3.47
Enterprise Value Over EBITDA39.03
EV to Operating Cash Flow24.03
Earnings Yield1.68%
Free Cash Flow Yield3.61%
security
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Shandong Wohua Pharmaceutical Co., Ltd. (002107.SZ) on the SHZ in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is 68.215 in 2024.

What is the ticker symbol of Shandong Wohua Pharmaceutical Co., Ltd. stock?

The ticker symbol of Shandong Wohua Pharmaceutical Co., Ltd. stock is 002107.SZ.

What is company IPO date?

IPO date of Shandong Wohua Pharmaceutical Co., Ltd. is 2007-01-24.

What is company current share price?

Current share price is 5.040 CNY.

What is stock market cap today?

The market cap of stock today is 2909138400.000.

What is PEG ratio in 2024?

The current -0.238 is -0.238 in 2024.

What is the number of employees in 2024?

In 2024 the company has 1353.